Suk‐Young Yoo

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 288 citations · Full text

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · The Lancet Oncology · 2023 · 90 citations

Surgical Oncology, Survival Outcomes, Neoadjuvant Cemiplimab +9

Analysis of Gene Expression in Resynthesized Brassica napus Allopolyploids Using Arabidopsis 70mer Oligo Microarrays

Robert T. Gaeta, Suk‐Young Yoo, J. Chris Pires et al. · PLoS ONE · 2009 · 73 citations · Full text

Differential sensitivity of the <i>Arabidopsis thaliana</i> transcriptome and enhancers to the effects of genome doubling

Daniela Pignatta, Brian P. Dilkes, Suk‐Young Yoo et al. · New Phytologist · 2010 · 44 citations

A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6

Brett Hughes, Alexander Guminski, Samantha Bowyer et al. · Journal of the American Academy of Dermatology · 2024 · 40 citations

Skin Cancer, Medicine, Dermatology +6